4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-025128
Sinha Vikas sold 2,683 shares at an average $3.66 ($9,828)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-19 | Sale : show line 1 in the form 10b5-1 | −1,217 | $3.71 | $4,513 | 1,186,521 | D |
| 2023-04-20 | Sale : show line 2 in the form 10b5-1 | −1,466 | $3.63 | $5,315 | 1,185,055 | D |
| Open-market sales · 2,683 sh · avg $3.66 · $9,828 | ||||||
Loading xslF345X04/doc4.xml…